Clopidogrel CAS 113665-84-2: Comprehensive Product Guide
Table of Contents
1. Product Specifications & Comparative Analysis
| Parameter | Clopidogrel | Aspirin | Ticagrelor |
|---|---|---|---|
| CAS Number | 113665-84-2 | 50-78-2 | 274693-27-5 |
| Molecular Formula | C16H16ClNO2S | C9H8O4 | C23H28F2N6O4S |
| Therapeutic Class | P2Y12 inhibitor | NSAID | P2Y12 antagonist |
2. Clinical Applications & Usage Scenarios
Primary Indications:
- Acute coronary syndrome management
- Post-percutaneous coronary intervention care
- Cerebrovascular accident prophylaxis
3. Administration Guidelines & Best Practices
Dosage Protocols:
- Initial loading dose: 300-600 mg
- Maintenance: 75 mg daily
- Renal impairment adjustment requirements
4. Case Studies: Therapeutic Outcomes
Case 1: 68-year-old male with NSTEMI showed 40% reduction in recurrent ischemia events with dual antiplatelet therapy (DAPT) combining clopidogrel and aspirin.
5. Enterprise Implementation Examples
PharmaHealth Inc. (2019-2022):
- Annual consumption: 850 kg
- Application: Cardiovascular drug formulations
- Outcome: 92% production batch compliance
6. Procurement Considerations
| Factor | Industry Benchmark |
|---|---|
| Purity Standard | ≥99.5% (HPLC) |
| Packaging | 25kg fiber drums with polyethylene lining |
Request Customized Solutions
Contact our API specialists for bulk pricing and COA documentation:
Email: info@vivalr.com
Tel: (86) 15866781826



评论
目前还没有评论。